DCF Advisers’s Biohaven BHVN Stock Holding History

DCF Advisers’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.7M	Sell	127,500 -2,500	-2%	-$36.2K	0.38%	54
2026 Q2	$1.93M	Buy	130,000 +6,500	+5%	+$70K	0.34%	49
2026 Q1	$1.04M	Sell	123,500 -28,000	-18%	-$306K	0.28%	57
2025 Q4	$1.71M	Sell	151,500 -20,000	-12%	-$248K	0.46%	53
2025 Q3	$2.57M	Buy	171,500 +115,000	+204%	+$1.67M	0.83%	35
2025 Q2	$797K	Buy	56,500 +6,000	+12%	+$107K	0.37%	59
2025 Q1	$1.21M	Buy	50,500 +14,500	+40%	+$511K	0.58%	48
2024 Q4	$1.34M	Buy	36,000 +5,000	+16%	+$233K	0.65%	46
2024 Q3	$1.55M	Sell	31,000 -20,700	-40%	-$805K	0.62%	38
2024 Q2	$1.79M	Buy	+51,700	New	+$2.04M	0.92%	31

Other funds holding BHVN

Capricorn Fund Managers London, United Kingdom $1.06B AUM 45.98% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

QTR Family Wealth Lake Mary, Florida $270M AUM 34.3% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Oak Ridge Investments Chicago, Illinois $1.68B AUM 48.52% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Novem Group Rochester, New York $1.01B AUM 13.42% 1-Year Est. Return

DCF Advisers's BHVN Position: Q3 2026 in Review

DCF Advisers reduced its Biohaven (BHVN) stake by 1.9% in Q3 2026, selling an estimated $36.2K and leaving 127,500 shares worth $1.7M. The position accounts for 0.38% of the portfolio, ranked #54.

DCF Advisers first reported a position in BHVN in Q2 2024 and has held it in 10 quarters since. The position peaked at $2.57M in Q3 2025. 86 funds tracked by Wall St. Rank hold BHVN as of Q3 2026.

DCF Advisers held 127,500 shares of Biohaven worth $1.7M as of Q3 2026.
DCF Advisers sold 2,500 Biohaven shares in Q3 2026, an estimated $36.2K.
Biohaven made up 0.38% of DCF Advisers's portfolio in Q3 2026, its #54 holding.
DCF Advisers first reported a position in Biohaven in Q2 2024 and has held it in 10 quarters since.
DCF Advisers's Biohaven position peaked at $2.57M in Q3 2025.
86 funds tracked by Wall St. Rank held Biohaven as of Q3 2026.

Based on DCF Advisers's 13F filing for Q3 2026, filed 4 Nov 2026.